首页> 外文期刊>Molecular cancer research: MCR >Breast field cancerization: isolation and comparison of telomerase-expressing cells in tumor and tumor adjacent, histologically normal breast tissue.
【24h】

Breast field cancerization: isolation and comparison of telomerase-expressing cells in tumor and tumor adjacent, histologically normal breast tissue.

机译:乳腺癌:分离和比较肿瘤及组织学正常的邻近乳腺组织中端粒酶表达细胞。

获取原文
获取原文并翻译 | 示例
           

摘要

Telomerase stabilizes chromosomes by maintaining telomere length, immortalizes mammalian cells, and is expressed in more than 90% of human tumors. However, the expression of human telomerase reverse transcriptase (hTERT) is not restricted to tumor cells. We have previously shown that a subpopulation of human mammary epithelial cells (HMEC) in tumor-adjacent, histologically normal (TAHN) breast tissues expresses hTERT mRNA at levels comparable with levels in breast tumors. In the current study, we first validated a reporter for measuring levels of hTERT promoter activity in early-passage HMECs and then used this reporter to compare hTERT promoter activity in HMECs derived from tumor and paired TAHN tissues 1, 3, and 5 cm from the tumor (TAHN-1, TAHN-3, and TAHN-5, respectively). Cell sorting, quantitative real-time PCR, and microarray analyses showed that the 10% of HMECs with the highest hTERT promoter activity in both tumor and TAHN-1 tissues contain more than 95% of hTERT mRNA and overexpress many genes involved in cell cycle and mitosis. The percentage of HMECs within this subpopulation showing high hTERT promoter activity was significantly reduced or absent in TAHN-3 and TAHN-5 tissues. We conclude that the field of "normal tissue" proximal to the breast tumors contains a population of HMECs similar in hTERT expression levels and in gene expression to the HMECs within the tumor mass and that this population is significantly reduced in tissues more distal to the tumor.
机译:端粒酶通过维持端粒长度来稳定染色体,使哺乳动物细胞永生化,并在90%以上的人类肿瘤中表达。但是,人端粒酶逆转录酶(hTERT)的表达不限于肿瘤细胞。先前我们已经表明,在邻近肿瘤,组织学正常(TAHN)的乳腺组织中,人类乳腺上皮细胞(HMEC)的亚群表达的hTERT mRNA的水平与乳腺肿瘤中的水平相当。在当前的研究中,我们首先验证了一个用于测量早期传代HMEC中hTERT启动子活性水平的报告基因,然后使用该报告子来比较源自肿瘤以及距该细胞1、3和5 cm的配对TAHN组织的HMEC中hTERT启动子活性。肿瘤(分别为TAHN-1,TAHN-3和TAHN-5)。细胞分选,实时荧光定量PCR和微阵列分析表明,在肿瘤和TAHN-1组织中,具有最高hTERT启动子活性的HMEC中有10%含有超过95%的hTERT mRNA,并且过表达许多参与细胞周期和有丝分裂。在TAHN-3和TAHN-5组织中,显示高hTERT启动子活性的亚群中的HMEC百分比显着降低或不存在。我们得出的结论是,靠近乳腺肿瘤的“正常组织”区域包含一组在肿瘤组织内的hTERT表达水平和基因表达与HMEC相似的HMEC,并且在远离肿瘤的组织中该人群显着减少。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号